0000908662-15-000097.txt : 20150226 0000908662-15-000097.hdr.sgml : 20150226 20150226162909 ACCESSION NUMBER: 0000908662-15-000097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150226 FILED AS OF DATE: 20150226 DATE AS OF CHANGE: 20150226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashe Andrew D. CENTRAL INDEX KEY: 0001573163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 15652944 MAIL ADDRESS: STREET 1: C/O DYAX CORP. STREET 2: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-02-26 0000907562 DYAX CORP DYAX 0001573163 Ashe Andrew D. C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 0 1 0 0 General Counsel & EVP Common Stock 2015-02-26 4 S 0 1500 15.34 D 36527 D The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The sales were primarily intended to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock. Includes 1,750 shares acquired under Dyax Corp.'s 1998 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c). /s/ Stacie S. Aarestad as attorney-in-fact 2015-02-26